Skip to content

Laparoscopic or Conventional Mesh Repair of Incisional and Umbilical Hernia

A Prospective, Multicenter, Randomized Trial Comparing Laparoscopy VS Conventional Mesh Repair of Incisional and Umbilical Hernia

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00970515
Acronym
EVENTRALAP
Enrollment
98
Registered
2009-09-02
Start date
2009-11-30
Completion date
2013-04-30
Last updated
2021-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incisional Hernia, Umbilical Hernia

Keywords

Laparoscopy, Incisional hernia, Umbilical hernia, Mesh repair, Postoperative complications

Brief summary

The aim of this study is to compare immediate and long-term (24 months) results of laparoscopic and open mesh repair of incisional and umbilical hernia.

Detailed description

The aim of this study is to compare immediate and long-term (24 months) results of laparoscopic and open mesh repair of incisional and umbilical hernia. Five hundred patients will be included in this randomized, multicentric trial. Hypotheses are that laparoscopic approach: 1- reduces immediate parietal complications without increasing intra abdominal septic complications 2- is less invasive and also reduces patients' hospital stay and recovery time; 3- has the same efficacy, than open approach.

Interventions

PROCEDURELaparoscopic mesh hernia repair

The mesh is intraperitoneal

PROCEDUREOpen anterior approach

The mesh is placed by an anterior approach. It is placed after incision of the skin over or under the abdominal muscles, or is intraperitoneal

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 18 * Incisional or umbilical hernia over 2 cm and less than 6 cm in diameter

Exclusion criteria

* Patients with a complicated incisional (pain, occlusion, cutaneous necrosis), irreductible painless incisional or umbilical hernia will not be considered as a complication * Patients with a recurrence of incisional hernia * Patients with an incisional or umbilical hernia whose lateral edges are located so that fixation of the mesh (which must extend beyond the 4 to 5 cm) is not possible * Pregnant women * Patients with HIV therapy * Patients with cirrhotic ascites or other signs of hepatic insufficiency (bilirubin\> 35 micromol / l; TP \< 55%) or significant thrombocytopenia (\< 60 000 platelets) * Patients with a contra indication for laparoscopy * Patients with a life expectancy \< one year, or whose mobility within two years of treatment will damage proper monitoring * Patients unable to understand information about the protocol

Design outcomes

Primary

MeasureTime frame
Parietal postoperative complications: 1- haematoma, 2- abscess, 3- seroma 4- cutaneous necrosis2 months
Postoperative intra abdominal complications: peritonitis, occlusion, haemorrhage2 months

Secondary

MeasureTime frame
Postoperative ileus2 months
Postoperative phlebitis2 months
Postoperative pulmonary embolism2 months
Postoperative urinary infection2 months
Duration of hospital stay2 months
Postoperative pain: measured by a- Visual Analogic Score (VAS 0-10): 1-number of days with VAS > 5; 2- maximal VAS, and b- duration (days) of morphine use2 months
Mesh infection24 months
Peritonitis due to intraperitoneal mesh24 months
Occlusion due to intra peritoneal mesh2 months
Recurrence of incisional or umbilical hernia24 months
Trocar site hernia24 months
Duration of drainage2 months
Postoperative fever > 38°52 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026